CIK: 0001839948
Total reported value
$3.5B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | Stock-Other | 29.70% | -11.09% | +17.42% | |
| 2 | CGON | Cg Oncology INC | Stock-Other | 7.27% | +2.07% | — | |
| 3 | COGT | Cogent Biosciences INC | Stock-Other | 4.80% | -1.45% | -2.39% | |
| 4 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 4.17% | -0.02% | +5.05% | |
| 5 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 3.74% | +1.32% | +8.50% | |
| 6 | TNGX | Tango Therapeutics INC | Stock-Other | 3.53% | +2.56% | -20.49% | |
| 7 | OCUL | Ocular Therapeutix INC | Stock-Other | 3.52% | -1.91% | +15.00% | |
| 8 | DNTH | Dianthus Therapeutics INC | Stock-Other | 3.25% | +1.74% | +11.65% | |
| 9 | TRML | Tourmaline Bio INC | Stock-Other | 3.09% | — | -11.22% | |
| 10 | DYN | Dyne Therapeutics INC | Stock-Other | 2.87% | -0.60% | +22.53% | |
| 11 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 2.82% | -1.06% | EXIT | |
| 12 | EYPT | Eyepoint INC | Stock-Other | 2.50% | -2.16% | EXIT | |
| 13 | FULC | Fulcrum Therapeutics INC | Stock-Other | 2.38% | -0.81% | — | |
| 14 | SVRA | Savara INC | Stock-Other | 2.17% | -0.54% | — | |
| 15 | RAPT | Rapt Therapeutics INC | Stock-Other | 2.08% | -2.89% | EXIT | |
| 16 | TYRA | Tyra Biosciences INC | Stock-Other | 1.99% | +1.04% | — | |
| 17 | UPB | Upstream Bio INC | Stock-Other | 1.96% | -0.62% | -24.44% | |
| 18 | LQDA | Liquidia CORP | Stock-Other | 1.91% | -1.51% | — | |
| 19 | IRON | Disc Medicine INC | Stock-Other | 1.51% | +2.45% | NEW | |
| 20 | GPCR | Structure Therapeutics INC | Stock-Other | 1.46% | -1.93% | — | |
| 21 | XNCR | Xencor INC | Stock-Other | 1.41% | -0.39% | — | |
| 22 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 1.36% | +0.01% | — | |
| 23 | RVMD | Revolution Medicines INC | Stock-Healthcare | 1.00% | +0.45% | — | |
| 24 | CATBUSD | Astria Therapeutics INC | Stock-Other | 0.99% | — | — | |
| 25 | KRRO | Korro Bio INC | Stock-Other | 0.98% | +0.02% | — | |
| 26 | KOD | Kodiak Sciences INC | Stock-Other | 0.92% | +0.24% | — | |
| 27 | SYRE | Spyre Therapeutics INC | Stock-Other | 0.91% | +0.68% | — | |
| 28 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 0.77% | -0.15% | — | |
| 29 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.70% | -0.35% | — | |
| 30 | ARVN | Arvinas INC | Stock-Other | 0.68% | -0.33% | — | |
| 31 | MNPR | Monopar Therapeutics INC | Stock-Other | 0.61% | -0.10% | — | |
| 32 | MBX | Mbx Biosciences INC | Stock-Other | 0.56% | — | — | |
| 33 | VTGN | Vistagen Therapeutics INC | Stock-Other | 0.47% | — | — | |
| 34 | RLAY | Relay Therapeutics INC | Stock-Other | 0.46% | +0.32% | — | |
| 35 | AVU0 | Adverum Biotechnologies INC | Stock-Other | 0.37% | — | -7.14% | |
| 36 | AVTX | Avalo Therapeutics INC | Stock-Other | 0.30% | +0.03% | — | |
| 37 | ✓ | Adc Therapeutics SA | Stock-Other | 0.27% | -0.11% | — | |
| 38 | PEPG | Pepgen INC | Stock-Other | 0.27% | — | — | |
| 39 | TRDA | Entrada Therapeutics INC | Stock-Other | 0.17% | +0.12% | — | |
| 40 | VTYXUSD | Ventyx Biosciences INC | Stock-Other | 0.05% | -0.09% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | +24.5% | +17.42% | Add |
| 2 | TNGX | Tango Therapeutics INC | +1.5% | -20.49% | Trim |
| 3 | AMLX | Amylyx Pharmaceuticals INC | +1.3% | +5.05% | Add |
| 4 | KOD | Kodiak Sciences INC | +0.5% | — | Unchanged |
| 5 | FULC | Fulcrum Therapeutics INC | +0.3% | — | Unchanged |
| 6 | TRML | Tourmaline Bio INC | 0% | -11.22% | Trim |
| 7 | VTYXUSD | Ventyx Biosciences INC | — | — | Unchanged |
| 8 | MBX | Mbx Biosciences INC | -0.1% | — | Unchanged |
| 9 | EYPT | Eyepoint INC | -0.1% | — | Unchanged |
| 10 | AVTX | Avalo Therapeutics INC | -0.2% | — | Unchanged |
| 11 | UPB | Upstream Bio INC | -0.4% | -24.44% | Trim |
| 12 | SLN | Silence Therapeutics Plc-adr | -0.4% | — | Unchanged |
| 13 | VTGN | Vistagen Therapeutics INC | -0.4% | — | Unchanged |
| 14 | DNTH | Dianthus Therapeutics INC | -0.5% | +11.65% | Add |
| 15 | TRDA | Entrada Therapeutics INC | -0.6% | — | Unchanged |
| 16 | AVU0 | Adverum Biotechnologies INC | -0.7% | -7.14% | Trim |
| 17 | COGT | Cogent Biosciences INC | -0.9% | -2.39% | Trim |
| 18 | DYN | Dyne Therapeutics INC | -0.9% | +22.53% | Add |
| 19 | CATBUSD | Astria Therapeutics INC | -1% | — | Unchanged |
| 20 | GPCR | Structure Therapeutics INC | -1.1% | — | Unchanged |
| 21 | IRON | Disc Medicine INC | -1.6% | — | Unchanged |
| 22 | TYRA | Tyra Biosciences INC | -1.7% | — | Unchanged |
| 23 | OCUL | Ocular Therapeutix INC | -1.8% | +15.00% | Add |
| 24 | 260 | Centessa Pharmaceuticals-adr | -1.9% | +8.50% | Add |
| 25 | XNCR | Xencor INC | -2.2% | — | Unchanged |
| 26 | SVRA | Savara INC | -2.5% | — | Unchanged |
| 27 | CGON | Cg Oncology INC | -5% | — | Unchanged |
| 28 | AGIO | Agios Pharmaceuticals INC | — | NEW | New buy |
| 29 | RAPT | Rapt Therapeutics INC | — | NEW | New buy |
| 30 | MLYS | Mineralys Therapeutics INC | — | EXIT | Sold out |
| 31 | LQDA | Liquidia CORP | — | NEW | New buy |
| 32 | LBRX | Lb Pharmaceuticals INC | — | NEW | New buy |
| 33 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 34 | RVMD | Revolution Medicines INC | — | NEW | New buy |
| 35 | KRRO | Korro Bio INC | — | NEW | New buy |
| 36 | SLNOEUR | Soleno Therapeutics INC | — | EXIT | Sold out |
| 37 | SYRE | Spyre Therapeutics INC | — | NEW | New buy |
| 38 | ✓ | Rapt Therapeutics INC | — | EXIT | Sold out |
| 39 | URGN | UroGen Pharma Ltd. | — | NEW | New buy |
| 40 | ARVN | Arvinas INC | — | NEW | New buy |
| 41 | MNPR | Monopar Therapeutics INC | — | NEW | New buy |
| 42 | CMPS | Compass Pathways PLC | — | EXIT | Sold out |
| 43 | RLAY | Relay Therapeutics INC | — | NEW | New buy |
| 44 | KURA | Kura Oncology INC | — | EXIT | Sold out |
| 45 | ✓ | Third Harmonic Bio INC | — | EXIT | Sold out |
| 46 | ✓ | — | EXIT | Sold out | |
| 47 | ✓ | Adc Therapeutics SA | — | NEW | New buy |
| 48 | PEPG | Pepgen INC | — | NEW | New buy |
| 49 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 50 | CABA | Cabaletta Bio INC | — | EXIT | Sold out |